Chronic subdural hematomas are one of the most common neurosurgical conditions, accounting for over 90,000 hospitalizations annually. Current treatments, including surgery and embolization, are invasive and carry risks. This trial aims to introduce the first non-invasive therapeutic approach for cSDH, which could reduce the need for invasive procedures and improve patient outcomes.